Login

HealthBeacon is among four nominees in the Intelligent Automation - Best Use of RPA & Cognitive category, aiming to win the top award. 00:10:00

Share On Facebook Share On Twitter

The chief executive of HealthBeacon, Jim Joyce

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating Market Volatility and Personal Well-being Amid Economic Uncertainty
00:10:00
Don't Miss Out on Growth: The Power of Investing Early | Jonathan R. Harner - Owner, Financial Advisor of Wichita Wealth Management, LLC
00:10:00
Peter Thiels AI Investment Strategy|Peter Thiel,Managing Partner,Founders Fund
00:10:00
Blinder Diamond Project Overview
00:00:00
Well-recognized leader in Pathology and Immunology education/Andrew Lichtman, MD, PhD Professor of Pathology at Harvard Medical School
00:10:00
Alberto Orozco Discusses Indian Precious Metals' Strategy and Growth Plans in Bolivia and Beyond
00:10:00
Friend or Finance? Navigating Money Requests | MYRA SALZER - CFP of The Wealth Conservancy, Inc.
00:10:00
Market Pulse: Navigating Interest Rate Uncertainty with Bell Direct’s Morning Bell | Sydney Market Insights
00:00:00
Tobias S. Kohler, M.D., M.P.H. Urologist, Mayo Clinic / Ask Mayo Clinic: Erectile Dysfunction
00:10:00
Accelerator composed of 1800 serial entrepreneurs industry experts|Joseph Huang,CEO,StartX
00:00:00
Probiodrug pursues modified abeta approach to tackle Alzheimer's- Dr. Konrad Glund, CEO, Probiodrug
00:10:00
KBC Bank's Strong Performance in Q3 2023: Robust Profit and Strategic Initiatives | Johan Thijs, CEO, KBC Bank.

© 2017 - Neuhu+